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Purposes: We tested the hypotheses that women have greater impairment in calf muscle hemoglobin oxygen saturation
(StO2) in response to exercise thanmen, and that the sex-related difference in calf muscle StO2 would partially explain the
shorter claudication distances of women.
Methods:The study comprised 27men and 24 women with peripheral arterial disease limited by intermittent claudication.
Patients were characterized on calf muscle StO2 before, during, and after a graded treadmill test, as well as on
demographic and cardiovascular risk factors, ankle-brachial index (ABI), ischemic window, initial claudication distance
(ICD), and absolute claudication distance (ACD).
Results:Women had a 45% lower ACD than men (296 268 m vs 539 288 m; P .001) during the treadmill test. Calf
muscle StO2 declined more rapidly during exercise in women than in men; the time to reach minimum StO2 occurred 54%
sooner in women (226 241 vs 491 426 seconds; P .010). The recovery time for calf muscle StO2 to reach the resting
value after treadmill exercise was prolonged in women (383  365 vs 201  206 seconds; P  .036). Predictors of ACD
included the time from start of exercise to minimum calf muscle StO2, the average rate of decline in StO2 from rest to
minimum StO2 value, the recovery half-time of StO2, and ABI (R2  0.70; P < .001). The ACD of women remained
lower after adjusting for ABI (mean difference, 209 m; P .003), but was no longer significantly lower (mean difference,
72 m; P  .132) after further adjustment for the StO2 variables for the three calf muscles.
Conclusion: In patients limited by intermittent claudication, women have lower ACD and greater impairment in calf
muscle StO during and after exercise than men, the exercise-mediated changes in calf muscle StO are predictive of ACD,2 2
and women have similar ACD as men after adjusting for calf StO2 and ABI measures. ( J Vasc Surg 2009;50:77-82.)Intermittent claudication is a symptom of peripheral
arterial disease (PAD) and is associated with elevated rates
of mortality1-4 and morbidity.5 Intermittent claudication,
which is present in 5% of the United States population aged
55 years,6 occurs during ambulation when the peripheral
circulation is inadequate to meet the metabolic require-
ment of the active leg musculature. Women are less likely to
report classic symptoms of intermittent claudication than
men at all age groups7,8 and are more likely to have asymp-
tomatic PAD.9 The lower prevalence of intermittent clau-
dication in women may be a consequence of lower levels of
physical activity than men,10 reporting atypical leg symp-
toms that are not characteristic of the classical history of
intermittent claudication,8,11 or a combination of both.
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doi:10.1016/j.jvs.2008.12.065Once intermittent claudication is diagnosed, women lead
functionally dependent lifestyles9,12 and have a mortality
rate that is twofold higher than men.7
Women with intermittent claudication have shorter
walking distances to the onset of claudication pain and to
maximal claudication pain during standardized treadmill
exercise than men, even though their ankle-brachial
index (ABI) is similar.10 This finding suggests that
women may have greater muscular ischemia during ex-
ercise than men.
We have previously used the noninvasive technique of
near-infrared spectroscopy (NIRS) to assess hemoglobin
oxygen saturation (StO2) of the calf musculature during
exercise.13,14 This technique measures total hemoglobin
content of the tissue underneath the probe, which corre-
sponds to capillary blood volume.15 The StO2 measure-
ment of the calf provides real-time information on the
balance between oxygen delivery and oxygen extraction
during ambulation.13,16-22 In patients with intermittent
claudication, as muscle metabolic demand increases during
increasingly more intense exercise, insufficient blood flow
and oxygen are delivered to the calf musculature, resulting
in a decline in StO2. Thus, the change in calf muscle StO2
during exercise provides clinically useful information on
local ischemia in patients with intermittent claudication.
The purposes of this study were to compare the calf
muscle StO2 measured during standardized treadmill exer-
cise between men and women with intermittent claudica-
tion and to determine whether calf muscle StO2 explains
sex-related differences in claudication distances. Our hy-
potheses were that women would have greater impairment
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that the sex-related difference in calf muscle StO2 would
partially explain the shorter claudication distances of
women.
METHODS
Participants. Patients who were limited by intermit-
tent claudication secondary to vascular insufficiency were
recruited and screened for this study, as described else-
where.14 A similar number of men and women are seen in
the university vascular clinics and laboratories, which en-
hanced our ability to recruit a similar number of men and
women for this investigation. The procedures used in this
study were approved by theUniversity of OklahomaHealth
Sciences Center Institutional Review Board. Written in-
formed consent was obtained from each participant before
investigation.
Medical history, physical examination, and anthro-
pometry. Demographic information, height, weight, car-
diovascular risk factors, comorbid conditions, claudication
history, blood samples, pulse oximeter measurement, an-
thropometric measures,23 and a list of current medications
were obtained from a medical history and physical exami-
nation to begin the evaluation.
Gardner treadmill test. Patients performed a pro-
gressive, graded treadmill protocol until maximal claudica-
tion pain, as previously described.24 The initial claudication
distance (ICD) and the absolute claudication distance
(ACD) were both recorded to quantify the severity of
claudication. Exercise capacity was measured by oxygen
uptake at peak exercise with a Medical Graphics VO2000
metabolic system (Medical Graphics Inc, St. Paul, Minn).
The test-retest intraclass reliability coefficient with these
procedures is R  0.89 for ICD,24 R  0.93 for ACD,24
andR 0.88 for peak oxygen uptake.25 Patients who were
limited by intermittent claudication on this test were in-
cluded in this study, whereas those who stopped exercise
for other reasons were excluded.
ABI and ischemic window. As previously described,
ABI was obtained from the more severely diseased lower
extremity by the Doppler ultrasound imaging technique
before and at 1, 3, 5, and 7 minutes after the treadmill
test.24,26 The ischemic window was determined from the
reduction in ankle systolic blood pressure after treadmill
exercise compared with the resting baseline value.27
Hemoglobin StO2 of the calf musculature. Calf mus-
cle StO2wasmeasured before, during, and after exercise using
a continuous-wave, NIRS spectrometer (InSpectra model
325; Hutchinson Technology Inc, Hutchinson, Minn), an
optical cable attached to a 25-mm probe, InSpectra 2.0
software, and a dedicated laptop computer, as previously
described.14 The probe was attached to the skin over the
medial gastrocnemius muscle of the more severely affected
leg using a double-sided adhesive light-excluding patch.13
A baseline measure of calf muscle StO2 was obtained at rest
as patients stood on the treadmill for 2 minutes to allow for
equilibration. From the start of treadmill exercise, the
minimum StO2 value, the time taken to reach theminimumvalue, the absolute and percentage drops in calf muscle
StO2 from rest to the minimum exercise value, and the
average rate of decline from rest to the minimum exercise
value were obtained. The recovery times for StO2 to reach
one-half of the resting StO2 value (recovery half-time), to
reach the full resting StO2 value (recovery time), and to
reach themaximum StO2 value were calculated by subtract-
ing the time to end of exercise from the time recovery StO2
values were observed.
6-minute walk test. Patients performed an over-
ground, 6-minute walk test (6-MWT), and pain-free and
total distance walked during the test were recorded.28 The
test-retest intraclass reliability coefficient is R  0.75 for
distance to onset of claudication pain and R  0.94 for
total 6-MWT distance.28
Walking Impairment Questionnaire. Self-reported
ambulatory ability was evaluated using theWalking Impair-
ment Questionnaire (WIQ), a validated questionnaire for
PAD patients that assesses ability to walk at various speeds
and distances, and to climb stairs.29
Ambulatory activity monitoring. Daily ambulatory
activity was assessed using a step activity monitor (Step
Watch 3, Cyma Inc, Mountlake Terrace, Wash), as previ-
ously described.30 Ambulatory activity was measured dur-
ing 7 consecutive days in which patients were instructed to
wear the monitor during waking hours and to remove it
before retiring to bed. The step activity monitor was at-
tached to the right ankle above the lateral malleolus using
elastic Velcro straps and continuously recorded the number
of strides taken on a minute-to-minute basis. The accuracy
of the step activity monitor is 99%  1% in patients with
intermittent claudication.30
Statistical analyses. Differences in means of measure-
ment variables in men and women were examined using the
independent sample t test. Differences between sexes for
dichotomous variables were examined with 2 procedures.
A stepwise regression procedure with switching (probabil-
ity to enter .1 and probability to remove .15) was used
to select predictive models for ACD. Initially, body mass
index and ABI, dichotomous current smoking, and disease
status variables were used as the set of possible predictors.
The single variable ABI selected by the procedure was then
used as a covariate in an analysis of covariance (ANCOVA)
comparing ACD in men and women. The set of predictors
was expanded to include calf muscle StO2 variables, and a
second prediction model was obtained. An ANCOVA us-
ing these model variables as covariates was used to compare
ACD in men and women. All analyses were performed
using the NCSS statistical package (NCSS Inc, Kaysville,
Utah). Statistical significance was set at P  .05. Measure-
ments are presented as means  standard deviations.
RESULTS
The clinical characteristics of men and women with
intermittent claudication are summarized in Table I. The
groups were similar on all variables (P .05), except that
women were shorter (P .001) and there was a trend for
women to have a lower body weight (P .076). Exercise
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marized in Table II. Women had lower ACD (P .001),
peak oxygen uptake (P  .001), WIQ speed score (P 
.001), WIQ stair climbing score (P  .001), 6-MWT
pain-free distance (P .003), and 6-MWT total distance
(P  .001). Furthermore, fewer women walked contin-
uously during the 6-MWT than men (P  .001): 64% of
women stopped ambulating at some point during the
test. Although not significant, there was a trend for
Table I. Clinical characteristics of men and women with
intermittent claudication
Variables
Men
(n  27)
Women
(n  24) P
Age, years 69 (9) 67 (11) .522
Height, cm 174.4 (7.4) 160.9 (6.6) .001
Weight, kg 85.6 (19.0) 76.9 (14.7) .076
Body mass index, kg/m2 28.1 (6.0) 29.8 (6.0) .338
Ankle-brachial index 0.69 (0.19) 0.61 (0.19) .125
Race, % white 59 38 .121
Current smoking, % yes 33 48 .297
Diabetes, % yes 26 46 .138
Hypertension, % yes 89 79 .451
Dyslipidemia, % yes 78 88 .473
Values are means (SD) or percentage of subjects in each category.
Table II. Exercise performance of men and women with
intermittent claudication
Variablesa
Men
(n  27)
Women
(n  24) P
Initial claudication
distance, m 236 (151) 170 (118) .094
Actual claudication
distance, m 483 (258) 265 (156) .001
Peak oxygen uptake,
mL/kg/min 15.0 (4.4) 10.8 (2.9) .001
Walking economy,
mL/kg/min 10.8 (1.8) 9.7 (1.6) .024
Ischemic window,
mm Hg  min/m
After graded treadmill test 0.41 (0.48) 0.56 (0.54) .300
After walking economy
test 0.26 (0.45) 0.41 (0.59) .291
6-min walk pain-free
distance, m 242 (126) 140 (89) .003
6-min walk distance, m 394 (88) 277 (78) .001
6-min walk rating of
perceived exertion, score 12.7 (2.3) 13.3 (3.5) .484
Walked continuously for 6
min, % of subjects 88 36 .001
WIQ scores, %
Distance 51 (32) 35 (30) 0.079
Speed 46 (21) 25 (18) 0.000
Stair climbing 57 (25) 32 (27) 0.001
Daily ambulatory activity,
strides/d 3631 (2254) 3275 (2443) 0.590
WIQ, Walking Impairment Questionnaire.
a Values are means (SD), except where noted.women to have lower ICD (P  .094) and a WIQdistance score (P  .079). No group difference was
noted for the ischemic window (P  .300).
Measures of calf muscle hemoglobin StO2 of men and
women with intermittent claudication are summarized in
Table III. The time to reachminimum StO2 occurredmore
than 4 minutes sooner in women than in men (P  .010).
The Fig illustrates the similarity of dependency of ACD on
the time to minimum StO2 in men (R  0.580, R
2 
0.336, P  .002), women (R  0.622, R2  0.387, P 
.001), and in the total group (R 0.653,R2 0.427, P
.0001). In addition, the recovery time for calf muscle StO2
to reach the resting value after treadmill exercise was pro-
longed by 3 minutes in women (P  .036). The group
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Fig. Association between time to minimum calf muscle hemoglo-
bin oxygen saturation (StO2) and absolute claudication distance
(ACD) in men (black circles) and women (white circles) with
intermittent claudication.
Table III. Measures of calf muscle hemoglobin oxygen
saturation of men and women with intermittent
claudication from start of exercise to maximum recovery
Variablesa
Men
(n  27)
Women
(n  24) P
StO2 at rest, % saturation 59 (18) 51 (20) .120
Minimum StO2, % saturation 18 (20) 17 (21) .885
Time to minimum StO2, sec 491 (426) 226 (241) .010
Absolute drop in StO2, %
saturation 41 (20) 34 (16) .146
Drop in StO2, % 72 (28) 72 (29) .972
Average rate of decline in StO2
from rest to minimum
exercise value, % saturation/s 0.40 (0.62) 0.49 (0.48) .553
Recovery half-time of StO2, sec 143 (247) 183 (253) .575
Recovery time of StO2, sec 201 (206) 383 (365) .036
Recovery time to maximal
StO2, sec 618 (258) 766 (324) .082
Maximum recovery StO2,%
saturation 91 (8) 73 (21) .001
StO2, Oxygen saturation.
a Values are means (SD).results for the remaining variables were similar (P  .05).
ration
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women with intermittent claudication is compiled in
Table IV. A forward stepwise regression procedure was
used to enter into the model predicting ACD, the time to
minimum calf muscle StO2, the average rate of decline in
StO2 from rest to minimum exercise value, the recovery
half-time of StO2 after treadmill exercise, and ABI. The R
2
of the full model was 0.70, indicating that the four predic-
tors combined to explain 70% of the variance in ACD. The
differences in unadjusted and adjusted values of ACDof the
groups are reported in Table V. Women had a lower
unadjusted ACD than men (P  .001), which remained
lower after adjusting for ABI (P .003), indicating that sex
differences in ACD is not attributable to differences in ABI.
However, after further adjustment of the StO2 variables for
the three calf muscles, ACD was no longer significantly
lower in the women (P  .132).
DISCUSSION
The three major findings of this investigation are:
1. women have a lower ACDand reachminimumcalfmuscle
StO24 minutes sooner during exercise than men,
2. the time to minimum calf muscle StO2, the average rate
of decline in StO2 from rest to minimum StO2 value,
and the recovery half-time of StO2 after treadmill exer-
cise are predictive of ACD, and
3. women have similar ACD as men after adjusting for
Table IV. Regression model predicting absolute claudicatio
Variables Regression coefficie
Intercept 157.13
Ankle-brachial index 244.87
Time to minimum calf muscle StO2 0.56
Average rate of decline in calf muscle
StO2 from rest to minimum value 151.29
Recovery half-time of calf muscle StO2 0.25
CI, Confidence interval; SE, standard error; StO2, hemoglobin oxygen satu
a Adjusted for other variables.
Table V. Unadjusted and adjusted absolute claudication
distance of men and women with intermittent claudication
Variables
Men
(n  27)
Women
(n  24) P
ACD unadjusted (meters) 483 (50) 265 (32) 0.001
ACD adjusted for ABI
(meters) 468 (40) 281 (42) 0.003
ACD adjusted for ABI and
calf muscle StO2
variablesa (meters) 401 (26) 341 (27) 0.132
ABI, Ankle/brachial index; ACD, absolute claudication distance; StO2,
hemoglobin oxygen saturation.
Values are means (SEM).
aAdjusted for time to minimum StO2, the average rate of decline in StO2
from rest to minimum StO2 value, and recovery half-time of StO2.these calf muscle StO2 measures and ABI.Differences in calf muscle StO2 and claudication in
women and men. A key measure of calf muscle StO2
during exercise is the observed time to reach the minimum
StO2 value, because this measure is positively associated
with ICD and ACD and negatively associated with ischemic
window in patients with intermittent claudication.14
Women in the current study had a shorter time to reach
minimum calf muscle StO2 than men, suggesting a greater
impairment in the increase in capillary blood volume during
exercise.15 That ABI was not different between men and
women and that calf muscle StO2 was predictive of ACD
after adjusting for ABI indicates that the microcirculation is
important in exercise performance independent of the
macrocirculation.
The faster decline in calf muscle StO2 in women during
standardized treadmill walking is a novel finding and pro-
vides a possible physiologic explanation for their shorter
ACD compared with men noted in this study and in a
previous report.10 Indeed, the time to minimum calf mus-
cle StO2 was a highly significant predictor of ACD as well as
the average rate of decline in StO2 from rest to minimum
StO2 value and the recovery half-time of StO2 after exer-
cise. The longer recovery time of calf muscle StO2 in
women is a consequence of the greater impairment in calf
muscle StO2 during exercise than in men. Collectively,
these findings suggest that calf muscle StO2 measured
during and after exercise explains sex-related differences in
ACD, even after adjusting for ABI.
In contrast to the observation that the ACDwas shorter
in women than in men, the ICD was not significantly
different between the two groups. This finding does not
support our previous observation that women have a
shorter ICD.10 The discrepancy between the ICD results
from this study and our previous study is most likely due to
the smaller sample size of the current study. When the
mean difference in ICD between women and men is com-
pared, the results from the two studies are remarkably
similar. Women reached ICD 66 meters (28%) sooner than
men in this study, which is similar to our previous observa-
tion that women attained ICD 63 meters (33%) sooner.10
The greater ischemic response during exercise in women, as
measured by their shorter time to minimum calf muscle
StO2, has less impact on sex-related differences for ICD
tance of men and women with intermittent claudication
SE 95% CI Partial R2a P
94.42 347.31 to 33.04 . . . .103
125.42 7.74 to 497.47 0.078 .057
0.12 0.31 to 0.81 0.311 .001
65.86 18.65 to 283.94 0.105 .026
0.10 0.05 to 0.45 0.123 .016
.n dis
ntthan for ACD. This is probably a reflection of the time to
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association with ICD than with ACD.14
Differences in exercise performance in women and
men. In addition to having a shorter ACD, the peak
oxygen uptake was 28% lower in women than in men.
This is an expected finding and supports our earlier
observation of a lower peak oxygen uptake in women,10
indicating that they have lower cardiopulmonary fitness
than men. The impaired exercise performance of women
during maximal treadmill exercise also is evident during
the less intense 6-MWT, where the pain-free walk dis-
tance was 42% lower in women than in men, and the total
distance covered during the test was 30% lower in
women. Furthermore, far fewer women walked continu-
ously for the entire 6 minutes, as nearly two-thirds had to
stop at least once during the test. These results support
findings from another investigation that women with
PAD had a significantly lower 6-MWT distance than men
with PAD.8 Finally, the women in this study perceived
their ambulatory function to be more impaired than
men, as their scores on the WIQ walking speed and WIQ
stair climbing subscales were lower, which agrees with
our previous study.10
Limitations. This study has limitations that are asso-
ciated with the measurement of calf muscle StO2, as previ-
ously described.14 Briefly, myoglobinmay partially contrib-
ute to the calf muscle StO2 measurement, capillary and
venular blood having different oxygen saturations that may
mix in the local tissue, and the subcutaneous fat thickness
directly under the probe may interfere with the measure of
calf muscle StO2. However, we believe these limitations
have minimal influence on calf muscle StO2, as discussed
earlier.14
Another limitation is that differences in body composi-
tion between men and womenmay account for some of the
differences seen in this study. In a previous study, we found
that lean tissue mass of the legs was associated with peak
oxygen consumption in patients with intermittent claudi-
cation,31 but its relationship with ACD or calf muscle StO2
is not known. However, we believe that group differences
in leg lean tissue mass had minimal affect in the present
study because no difference in ACD was found between
men and women after adjustment for ABI and calf muscle
StO2 measures, suggesting that other factors did not con-
tribute to sex-differences in exercise performance.
An additional limitation is that hormonal replacement
therapy may have altered results, but this is unlikely because
only two women were on this regimen. Finally, the results
of this study are only applicable to PAD patients who are
limited by intermittent claudication, and thus may not be
generalizable to patients with different symptomatology.
CONCLUSIONS
In patients limited by intermittent claudication, women
have a lower ACDand greater impairment in calfmuscle StO2
during and after exercise than men, the exercise-mediated
changes in calf muscle StO2 are predictive of ACD, and
women have similar ACDs asmen after adjusting for calf StO2andABImeasures. These data support the hypothesis that the
greater impairment in calf muscle StO2 in women is a physi-
ologic mechanism for their shorter ACD.
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